Author Question: In the ABAB (reversal) research design, the person receiving the treatment is measured repeatedly ... (Read 46 times)

stock

  • Hero Member
  • *****
  • Posts: 573
In the ABAB (reversal) research design, the person receiving the treatment is measured repeatedly during:
 
  a. the A phases of the study.
  b. the B phases of the study.
  c. the first A phase and the second B phase of the study.
  d. all four phases of the study.

Question 2

In the ABAB (reversal) research design, which of the following refers to the second A measurement?
 
  a. Again under the influence of the therapeutic intervention
  b. During a subsequent period when the intervention is temporally discontinued
  c. During the time when the intervention is in effect
  d. Prior to intervention



sarajane1989

  • Sr. Member
  • ****
  • Posts: 296
Answer to Question 1

D

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

For a complete list of videos, visit our video library